Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antoni, M. H.
Right arrow Articles by Schneiderman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antoni, M. H.
Right arrow Articles by Schneiderman, N.
Related Collections
Right arrow Immunology
Right arrow Depression
Right arrow Therapeutic Interventions
Right arrow HIV/AIDS
Psychosomatic Medicine 68:143-151 (2006)
© 2006 American Psychosomatic Society

ORIGINAL ARTICLES

Randomized Clinical Trial of Cognitive Behavioral Stress Management on Human Immunodeficiency Virus Viral Load in Gay Men Treated With Highly Active Antiretroviral Therapy

Michael H. Antoni, PhD, Adam W. Carrico, MS, Ron E. Durán, PhD, Susan Spitzer, PhD, Frank Penedo, PhD, Gail Ironson, MD, PhD, Mary Ann Fletcher, PhD, Nancy Klimas, MD and Neil Schneiderman, PhD

From the Department of Psychology (M.H.A., A.W.C., R.E.D., S.S., F.P., G.I., N.S.), Department of Psychiatry (M.H.A., G.I., N.S.), and Department of Medicine (M.A.F., N.K., N.S.), University of Miami, Coral Gables, FL.

Address correspondence and reprint requests to Michael H. Antoni, PhD, Department of Psychology, 5665 Ponce De Leon Blvd, Coral Gables, FL 33146. E-mail: Mantoni{at}miami.edu

Objective: Human Immunodeficiency Virus (HIV)–positive individuals treated with highly active antiretroviral therapy (HAART) may experience psychological burdens and negative mood states, which could impair their ability to derive maximum benefits from their medical treatment. We tested whether a cognitive behavioral stress management (CBSM) intervention in combination with antiretroviral medication adherence training (MAT) from a clinical pharmacist influences HIV viral load more than MAT alone.

Methods: HIV-positive men who have sex with men were randomized to either a 10-week CBSM + MAT intervention (n = 76) or a MAT-Only condition (n = 54). Data were collected at baseline immediately following the 10-week intervention period, at 9 months postrandomization, and at 15 months postrandomization.

Results: We found no differences in HIV viral load among the 130 men randomized. However, in the 101 men with detectable viral load at baseline, those randomized to CBSM + MAT (n = 61) displayed reductions of 0.56 log10 units in HIV viral load over a 15-month period after controlling for medication adherence. Men in the MAT-Only condition (n = 40) showed no change. Decreases in depressed mood during the intervention period explained the effect of CBSM + MAT on HIV viral load reduction over the 15 months.

Conclusions: A time-limited CBSM + MAT intervention that modulates depressed mood may enhance the effects of HAART on suppression of HIV viral load in HIV+ men with detectable plasma levels.

Key Words: depression • HIV/AIDS • HIV viral load • intervention

Abbreviations: AIDS = acquired immunodeficiency syndrome; ACTG = Adherence to Combination Therapy Guide; BDI = Beck Depression Inventory; CBSM = cognitive behavioral stress management; CET = coping effectiveness training; EDTA = ethylenediaminetetraacetic acid; HAART = highly active antiretroviral therapy; HIV = human immunodeficiency virus; MAT = medication adherence training; MEMS = medication event monitoring system; POMS = Profile of Mood States.




This article has been cited by other articles:


Home page
 Psychosom. Med.Home page
G. Ironson and H. Hayward
Do Positive Psychosocial Factors Predict Disease Progression in HIV-1? A Review of the Evidence
Psychosom Med, June 1, 2008; 70(5): 546 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
A. W. Carrico and M. H. Antoni
Effects of Psychological Interventions on Neuroendocrine Hormone Regulation and Immune Status in HIV-Positive Persons: A Review of Randomized Controlled Trials
Psychosom Med, June 1, 2008; 70(5): 575 - 584.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
C. Gore-Felton and C. Koopman
Behavioral Mediation of the Relationship Between Psychosocial Factors and HIV Disease Progression
Psychosom Med, June 1, 2008; 70(5): 569 - 574.
[Abstract] [Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
S. Naar-King, P. Lam, B. Wang, K. Wright, J. T. Parsons, and M. A. Frey
Brief Report: Maintenance of Effects of Motivational Enhancement Therapy to Improve Risk Behaviors and HIV-related Health in a Randomized Controlled Trial of Youth Living with HIV
J. Pediatr. Psychol., May 1, 2008; 33(4): 441 - 445.
[Abstract] [Full Text] [PDF]

Home page
 Acad. PsychiatryHome page
D. H. Novack, O. Cameron, E. Epel, R. Ader, S. R. Waldstein, S. Levenstein, M. H. Antoni, and A. R. Wainer
Psychosomatic Medicine: The Scientific Foundation of the Biopsychosocial Model
Acad Psychiatry, October 1, 2007; 31(5): 388 - 401.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
A. W. Carrico, M. O. Johnson, J. T. Moskowitz, T. B. Neilands, S. F. Morin, E. D. Charlebois, W. T. Steward, R. H. Remien, F. L. Wong, M. J. Rotheram-Borus, et al.
Affect Regulation, Stimulant Use, and Viral Load Among HIV-Positive Persons on Anti-Retroviral Therapy
Psychosom Med, October 1, 2007; 69(8): 785 - 792.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Psychosomatic Society